George Abraham to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications George Abraham has written about Diabetes Mellitus, Type 2.
Connection Strength
0.144
-
Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkit NR, Gogtay M, Lal A, Abraham GM, Trivedi N. Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus. Respir Med. 2024 Nov-Dec; 234:107819.
Score: 0.144